412 related articles for article (PubMed ID: 30439491)
1. Extrudability analysis of drug loaded pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Coburn J; Asfari S; Ghammraoui B; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 554():292-301. PubMed ID: 30439491
[TBL] [Abstract][Full Text] [Related]
2. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
[TBL] [Abstract][Full Text] [Related]
3. A tunable extruded 3D printing platform using thermo-sensitive pastes.
Yang Y; Wang X; Lin X; Xie L; Ivone R; Shen J; Yang G
Int J Pharm; 2020 Jun; 583():119360. PubMed ID: 32335080
[TBL] [Abstract][Full Text] [Related]
4. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing.
Li Q; Guan X; Cui M; Zhu Z; Chen K; Wen H; Jia D; Hou J; Xu W; Yang X; Pan W
Int J Pharm; 2018 Jan; 535(1-2):325-332. PubMed ID: 29051121
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate.
Krkobabić M; Medarević D; Cvijić S; Grujić B; Ibrić S
Int J Pharm; 2019 Dec; 572():118790. PubMed ID: 31678382
[TBL] [Abstract][Full Text] [Related]
6. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
7. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of developing hospital preparation by semisolid extrusion 3D printing: personalized amlodipine besylate chewable tablets.
Han X; Kang D; Liu B; Zhang H; Wang Z; Gao X; Zheng A
Pharm Dev Technol; 2022 Feb; 27(2):164-174. PubMed ID: 35007187
[TBL] [Abstract][Full Text] [Related]
10. Semisolid Extrusion 3D Printing of Propranolol Hydrochloride Gummy Chewable Tablets: an Innovative Approach to Prepare Personalized Medicine for Pediatrics.
Zhu C; Tian Y; Zhang E; Gao X; Zhang H; Liu N; Han X; Sun Y; Wang Z; Zheng A
AAPS PharmSciTech; 2022 Jun; 23(5):166. PubMed ID: 35705726
[TBL] [Abstract][Full Text] [Related]
11. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
12. Desktop 3D printing of controlled release pharmaceutical bilayer tablets.
Khaled SA; Burley JC; Alexander MR; Roberts CJ
Int J Pharm; 2014 Jan; 461(1-2):105-11. PubMed ID: 24280018
[TBL] [Abstract][Full Text] [Related]
13. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
14. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
15. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release.
Yang Y; Wang H; Li H; Ou Z; Yang G
Eur J Pharm Sci; 2018 Mar; 115():11-18. PubMed ID: 29305984
[TBL] [Abstract][Full Text] [Related]
16. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
[TBL] [Abstract][Full Text] [Related]
17. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
[TBL] [Abstract][Full Text] [Related]
18. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
20. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
